©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 110861
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.110861
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.110861
Figure 3 Prospective evidence linking circulating C15:0 to cardiovascular events.
Pooled analysis of 18 prospective cohorts shows a 12% lower risk of incident cardiovascular disease among participants in the highest quintile of circulating C15:0 compared with the lowest, with minimal between-study heterogeneity (I2 = 14%). HR: Hazard ratio.
- Citation: Mercola J. Pentadecanoic acid (C15:0) and cardiovascular disease: A narrative review. World J Cardiol 2025; 17(12): 110861
- URL: https://www.wjgnet.com/1949-8462/full/v17/i12/110861.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i12.110861